Bild zu Biopharm

K. Kleinschmidt et al. / Biomaterials 34 (2013) 5926-5936

Enhanced reconstruction of long bone architecture by a growth factor mutant combining positive features of GDF-5 and BMP-2

By: Kerstin Kleinschmidt, Frank Ploeger, Joachim Nickel, Julia Glockenmeier, Pierre Kunz, Wiltrud Richter

The latest innovation of the BIOPHARM Growth Factor Platform Technology, the proprietary growth factor BB-1, has been reviewed in the publication “Enhanced reconstruction of long bone architecture by a growth factor mutant combining positive features of GDF-5 and BMP-2”, published by Kleinschmidt et al. in Biomaterials 34 (2013). The review demonstrates that BB-1, a recently patented Growth Factor developed by BIOPHARM, shows a superior bone growth potential over currently available bone morphogenic proteins (BMP).

download


« go back